Govx stock forecast 2025 quantitative models suggest GOVX stock

Quantitative models suggest GOVX stock forecast 2025 carries a Sharpe ratio potentially exceeding 1.2 under bullish biotech market conditions, signaling favorable risk-adjusted returns. Get the latest GeoVax Labs stock forecast for tomorrow and next week. Stay ahead of the game with our GOVX stock price prediction for 2025 and 2026 to 2030. We have seen 10 institutional investors add shares of GeoVax Labs stock to their portfolio, and 13 decrease their positions in their most recent quarter. Govx stock forecast 2025 points to potential volatility as biotech valuations remain sensitive to clinical trial outcomes. Analysts tracking NASDAQ small-cap biotech names suggest GOVX could trade in the $3.20–$5.80 range if upcoming vaccine-related data in late 2024 meets market expectations.